All News about Annovis Bio Inc
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
January 25, 2022
Via Newsfile
Exposures
Product Safety
Via NewMediaWire
Topics
Lawsuit
Via NewMediaWire
Topics
Lawsuit
LAWSUITS FILED AGAINST ANVS, EAR and HYZN - Jakubowitz Law Pursues Shareholders Claims
October 13, 2021
From Jakubowitz Law
Via AccessWire
Via NewMediaWire
Topics
Lawsuit
Via AccessWire
Topics
Lawsuit
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ANVS, VIEW and SESN
October 12, 2021
From The Klein Law Firm
Via AccessWire
Topics
Fraud
Exposures
Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|